Hinge Health Inc. (NYSE: HNGE - Get Free Report) CEO Daniel Perez sold 4,100 shares of Hinge Health

https://www.bloomberg.com/news/articles/2026-10-07/hinge-health-sees-hardware-deals-ahead-in-digital

Argent Capital Management LLC purchased a new stake in Hinge Health Inc. (NYSE: HNGE) during the und

Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the qu

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report

Hinge Health Inc. (NYSE: HNGE - Get Free Report) reached a new 52-week high during trading on Monday

Hinge Health Inc. (NYSE: HNGE - Get Free Report) reached a new 52-week high during mid-day trading o

Analysts revised targets and ratings for KMX, ARX, JKHY, MRNA, GO, HNGE, AYTU and MSFT, with mixed u

Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price

The healthcare sector has performed fairly well so far in 2026 due to several factors: GLP-1 medicat

Hinge Health Inc. (NYSE: HNGE - Get Free Report) President James Pursley sold 33,000 shares of Hinge

Baird analyst Vikram Kesavabhotla maintains Hinge Health (NYSE:HNGE) with a Neutral and raises th

CorVel (NASDAQ: CRVL - Get Free Report) and Hinge Health (NYSE: HNGE - Get Free Report) are both mid

HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support it

Hinge Health Inc. (NYSE: HNGE - Get Free Report) Chairman Gabriel Mecklenburg sold 150,000 shares of

Hinge Health Inc. (NYSE: HNGE - Get Free Report) Chairman Gabriel Mecklenburg sold 250,000 shares of

Cramer favored ET, PANW and CRWD over SentinelOne, advised waiting on Corning, called GEMI speculati

Hinge Health Inc. (NYSE: HNGE - Get Free Report) CFO James Budge sold 55,561 shares of Hinge Health

Concurrent Investment Advisors LLC reduced its position in Hinge Health Inc. (NYSE: HNGE) by 45.2% d

Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price

The transaction reduced her direct equity position by 4% while maintaining a multi-million dollar st

Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock?

Bond yields have the entire stock market on edge. The last thing most investors are thinking about i

Oura Health is preparing for a potential U.S. IPO that could raise up to $3 billion and value the sm

Hinge stock found support at a key level in recent weeks and is approaching multiple new buy points

Many people know that seemingly unrelated symptoms can be connected. But in most cases, treating ind

Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion int

Mad Money Lightning Round analysis: Hinge Health a buy after strong quarter, Stellantis not investib

Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raise

RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises

Citizens analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and rai

Wells Fargo analyst Stan Berenshteyn maintains Hinge Health (NYSE:HNGE) with a Overweight and rai

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperfor

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the

Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP

Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price

Hinge Health (NYSE:HNGE) raises FY2026 sales outlook from $818.000 million-$824.000 million to $856.

Hinge Health (NYSE:HNGE) reported quarterly earnings of $0.59 per share which met the analyst consen

Citizens analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and rai

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the

Keybanc analyst Scott Schoenhaus maintains Hinge Health (NYSE:HNGE) with a Overweight and raises

Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and

Wells Fargo analyst Stan Berenshteyn maintains Hinge Health (NYSE:HNGE) with a Overweight and rai

Baird analyst Vikram Kesavabhotla maintains Hinge Health (NYSE:HNGE) with a Neutral and raises th

Raymond James analyst Brian Peterson maintains Hinge Health (NYSE:HNGE) with a Outperform and rai

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises

Keybanc analyst Scott Schoenhaus maintains Hinge Health (NYSE:HNGE) with a Overweight and raises

RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises

Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raise